Scientists say that those who do not drink coffee are almost one and a half more likely to develop multiple sclerosis, compared to coffee aficionados who enjoy more than a cup of their favorite beverage daily.
This is due to the effects of the caffeine, which has previously been associated with reducing the risk of Alzheimer’s and Parkinson’s disease.
Previous studies have shown that drinking four cups of coffee daily can lower the risk of developing diabetes by approximately 25%.
Recent statistics reveal that more than 2.5 million people worldwide suffer from multiple sclerosis.
This is a medical condition that attacks the central nervous system, damaging the coating around the nerve fibers.
The symptoms depend on which region of the central nervous system was affected and what was the purpose of the affected nerve.
Some of the symptoms of multiple sclerosis include fatigue, problems walking and eye problems. The condition usually affect people aged 20 to 40, and it’s more common in women than in men.
The scientists have recently analyzed the data collected from two US and Swedish studies.
They compared the data from more than 2,788 patients who have been diagnosed with multiple sclerosis with the data from more than 4,000 healthy participants.
Both studies showed that the participants who were not coffee drinkers were more likely to develop multiple sclerosis, compared to the volunteers who drank at least one cup a day.
According to the Swedish study, those who didn’t drink any coffee were one and a half times more likely to develop the MS, compared to those who drank minimum of six cups daily.
Dr. Ellen Mowry, one of the researchers involved in the study and a medical expert at the Johns Hopkins University School of Medicine, Baltimore, explained that caffeine is known to reduce the risk of Parkinson’s and Alzheimer’s.
The recent findings suggest that caffeine also plays an important role against multiple sclerosis, proving that caffeine is indeed beneficial for the brain.
The authors of the study presented their findings at the American Academy of Neurology meeting held in annually in Washington DC.
Image Source: naturesgardenexpress